Global Alpha Capital Management Ltd. Lowers Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Global Alpha Capital Management Ltd. reduced its stake in Option Care Health by 15.5%, selling 10,649 shares, resulting in holdings worth approximately $2.03 million.
• Institutional investors hold about 98.05% of Option Care Health's stock, with Wells Fargo and Renaissance Technologies making significant increases in their positions during the previous quarter.
• Option Care Health reported $1.42 billion in revenue for the last quarter, exceeding estimates, with an earnings per share of $0.41, surpassing analyst expectations.

Global Alpha Capital Management Ltd. trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 15.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 58,161 shares of the company's stock after selling 10,649 shares during the quarter. Global Alpha Capital Management Ltd.'s holdings in Option Care Health were worth $2,033,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of OPCH. Wells Fargo & Company MN boosted its holdings in Option Care Health by 9.5% during the 4th quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock valued at $4,185,000 after acquiring an additional 15,609 shares during the period. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Bank of Nova Scotia purchased a new position in Option Care Health during the 4th quarter valued at about $228,000. Renaissance Technologies LLC boosted its holdings in Option Care Health by 2,032.6% during the 4th quarter. Renaissance Technologies LLC now owns 330,546 shares of the company's stock valued at $7,669,000 after acquiring an additional 315,046 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in Option Care Health during the 4th quarter valued at about $2,027,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $28.20 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market capitalization of $4.58 billion, a PE ratio of 22.56, a price-to-earnings-growth ratio of 1.76 and a beta of 0.79. The stock's 50-day simple moving average is $30.64 and its 200-day simple moving average is $31.92.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter last year, the company earned $0.30 EPS. The business's quarterly revenue was up 15.4% on a year-over-year basis. As a group, equities research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analyst Ratings Changes

OPCH has been the subject of a number of research analyst reports. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities increased their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.